Thus, inflammation-mediated disruption of the metabolic cross-talk between the adipose tissue and the liver may account for reduced PPARα activity, mitochondrial dysfunction, and NASH development (Figure 2). This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.